Relationship between CsA trough blood concentration and severity of acute graft-versus-host disease after paediatric stem cell transplantation from matched-sibling or unrelated donors-Reference-Cited by-同舟云学术

Relationship between CsA trough blood concentration and severity of acute graft-versus-host disease after paediatric stem cell transplantation from matched-sibling or unrelated donors

Published:2003-10 Issue:8 Volume:32 Page:777-784
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Martin P,Bleyzac N,Souillet G,Galambrun C,Bertrand Y,Maire P H,Jelliffe R W,Aulagner G

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1704213.pdf

Reference42 articles.

1. Gale RP, Bortin MM, van Bekkum DW et al. Risk factors for acute graft-versus-host disease. Br J Haematol 1987; 67: 397–406.

2. Weisdorf D, Hakke R, Blazar B et al. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation 1991; 51: 1197–1203.

3. Nash RA, Pepe MS, Storb R et al. Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 1992; 80: 1838–1845.

4. Hägglund H, Bostrom L, Remberger M et al. Risk factors for acute graft-versus-host disease in 291 consecutive HLA-identical bone marrow transplantation. Bone Marrow Transplant 1995; 16: 747–753.

5. Locatelli F, Uderzo C, Dini G et al. Graft-versus-host disease in children: the AIEOP-BMT Group experience with cyclo-sporin A. Bone Marrow Transplant 1993; 12: 627–633.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Higher cyclosporine-A concentration increases the risk of relapse in AML following allogeneic stem cell transplantation from unrelated donors using anti-thymocyte globulin;Scientific Reports;2023-12-20

2. Reaching the cyclosporine a level target slowly in four weeks correlates with better prognosis for Chinese patients after allogeneic haematopoietic cell transplantation;Hematology;2023-11-17

3. Optimizing cyclosporine A dose post allogeneic hematopoietic stem cell transplantation in paediatric cancer patients;Journal of Oncology Pharmacy Practice;2023-08-01

4. Timing of cyclosporine administration for GvHD prophylaxis in haploidentical stem cell transplantation setting: Single center experience;Current Research in Translational Medicine;2023-04

5. Lower levels of cyclosporine between days 0 and +21 may reduce later relapses without increasing graft‐versus‐host disease in children and adolescents with acute lymphoblastic leukemia who undergo myeloablative TBI ‐based allogeneic hematopoietic cell transplantation;European Journal of Haematology;2022-05-29